We are live on ! Find out more
XK

Xact Kapitalforvaltning Portfolio holdings

AUM $4.7B
1-Year Est. Return 0.05%
This Fund
S&P 500
This Quarter Est. Return
+10.95%
1 Year Est. Return
-0.05%
3 Year Est. Return
+34.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.88B
AUM Growth
+$618M
Cap. Flow
+$106M
Cap. Flow %
1.8%
Top 10 Hldgs %
22.46%
Holding
1,459
New
30
Increased
469
Reduced
96
Closed
51

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$9.68M
2
AMZN icon
Amazon
AMZN
+$6.71M
3
MSFT icon
Microsoft
MSFT
+$5.34M
4
META icon
Meta Platforms (Facebook)
META
+$3.18M
5
CRM icon
Salesforce
CRM
+$2.99M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$17.5M
2
TFC icon
Truist Financial
TFC
+$8.4M
3
STI
SunTrust Banks, Inc.
STI
+$6.79M
4
DOC icon
Healthpeak Properties
DOC
+$4.82M
5
GEN icon
Gen Digital
GEN
+$2.93M

Sector Composition

Rank Sector Weight
1 Technology 23.11%
2 Financials 15.93%
3 Healthcare 15.67%
4 Consumer Discretionary 12.39%
5 Communication Services 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEG icon
601
Leggett & Platt
LEG
$1.31B
$1.04M 0.02%
20,500
+10,100
+97% +$495K
AVLR
602
DELISTED
Avalara, Inc.
AVLR
$1.03M 0.02%
14,000
+4,600
+49% +$334K
FHN icon
603
First Horizon
FHN
$12.1B
$1.02M 0.02%
61,885
– –
INGR icon
604
Ingredion
INGR
$6.58B
$1.02M 0.02%
11,030
+2,948
+36% +$248K
HAE icon
605
Haemonetics
HAE
$4B
$1.02M 0.02%
8,895
– –
ATR icon
606
AptarGroup
ATR
$8.61B
$1.02M 0.02%
8,830
– –
JBGS
607
JBG SMITH
JBGS
$708M
$1.02M 0.02%
25,600
– –
GBT
608
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.02M 0.02%
12,844
+4,300
+50% +$255K
LOPE icon
609
Grand Canyon Education
LOPE
$3.98B
$1.02M 0.02%
10,630
+3,300
+45% +$305K
WAL icon
610
Western Alliance Bancorporation
WAL
$8.87B
$1.02M 0.02%
17,860
– –
Z icon
611
Zillow
Z
$7.56B
$1.01M 0.02%
22,000
– –
ACC
612
DELISTED
American Campus Communities, Inc.
ACC
$1.01M 0.02%
21,504
– –
ARWR icon
613
Arrowhead Research
ARWR
$12.4B
$1M 0.02%
15,800
– –
BPOP icon
614
Popular Inc
BPOP
$11.1B
$1M 0.02%
17,039
– –
AMG icon
615
Affiliated Managers Group
AMG
$9.76B
$1M 0.02%
11,800
+5,900
+100% +$484K
ACAD icon
616
Acadia Pharmaceuticals
ACAD
$5.03B
$998K 0.02%
23,333
+3,401
+17% +$148K
BC icon
617
Brunswick
BC
$5.28B
$996K 0.02%
16,600
+8,500
+105% +$492K
JBL icon
618
Jabil
JBL
$35.8B
$994K 0.02%
24,048
– –
MKSI icon
619
MKS Inc
MKSI
$20.6B
$993K 0.02%
9,023
– –
SABR icon
620
Sabre
SABR
$835M
$992K 0.02%
44,200
– –
AGO icon
621
Assured Guaranty
AGO
$3.34B
$990K 0.02%
20,204
– –
DEI icon
622
Douglas Emmett
DEI
$1.96B
$990K 0.02%
22,560
– –
CRUS icon
623
Cirrus Logic
CRUS
$6.26B
$989K 0.02%
11,995
– –
CPRI icon
624
Capri Holdings
CPRI
$1.74B
$988K 0.02%
25,900
– –
LECO icon
625
Lincoln Electric
LECO
$15.4B
$988K 0.02%
10,216
– –
23 24
25
26 27

Similar funds

HFA
Harvest Fund Advisors Wayne, Pennsylvania $4.87B AUM 49.03% 1-Year Est. Return
BPSG
Brookfield Public Securities Group New York $6.17B AUM
PIA
Piedmont Investment Advisors Durham, North Carolina $2.53B AUM 0.83% 1-Year Est. Return
FTIOP
Fiduciary Trust International of Pennsylvania Radnor, Pennsylvania $2.14B AUM 3.72% 1-Year Est. Return
CEP
Chicago Equity Partners Chicago, Illinois $993M AUM 6.42% 1-Year Est. Return
EA
Echinus Advisors New York $881M AUM 6.76% 1-Year Est. Return
OWD
Osborn Williams & Donohoe Cincinnati, Ohio $762M AUM 2.74% 1-Year Est. Return
AVC
Arlington Value Capital Salt Lake City, Utah $688M AUM 23.52% 1-Year Est. Return

Xact Kapitalforvaltning's Q4 2019 Portfolio in Review

As of Q4 2019, Xact Kapitalforvaltning held 1,459 positions worth $5.88B, up 12% from $5.26B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Xact Kapitalforvaltning's Q4 2019 filing shows 30 new, 469 increased, 96 reduced and 51 closed positions. Its largest new stake was BeOne Medicines Ltd: 11,100 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Xact Kapitalforvaltning's largest Q4 2019 buy was BeOne Medicines Ltd: 11,100 shares worth $1.84M.
  • Xact Kapitalforvaltning added most to Alibaba in Q4 2019, an estimated $9.68M increase.
  • Xact Kapitalforvaltning's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.28M.
  • Xact Kapitalforvaltning fully exited Celgene Corp in Q4 2019, selling an estimated $17.5M.
  • Xact Kapitalforvaltning's ten largest holdings make up 22% of its $5.88B portfolio in Q4 2019.
  • Xact Kapitalforvaltning opened 30 new positions and closed 51 in Q4 2019.
  • Xact Kapitalforvaltning's portfolio value rose 12% quarter-over-quarter to $5.88B.

Based on Xact Kapitalforvaltning's 13F filing for Q4 2019, filed 14 Feb 2020.